India Infoline15m
Alembic Pharma Shares Jump on USFDA Approval for Lamotrigine Tablets
This approval enhances Alembic Pharma’s portfolio, which now totals 216 ANDAs from the USFDA, including 188 final and 28 ...
Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution
Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) Alcaftadine Ophthalmic Solution.
New web portal empowers drug discovery, systems-level analysis of critical kinase-substrate interactions
Researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to ...
Armed robbery in Revesby11h
Mount Sinai Launches Portal for Drug Discovery, Analysis
Researchers from the Icahn School of Medicine at Mount Sinai have introduced KiNet, an interactive web portal designed to ...
ophthalmologytimes12h
Aldeyra Therapeutics resubmits New Drug Application for reproxalap for the treatment of dry eye disease
Aldeyra Therapeutics has resubmitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for topical ...
Deccan Herald20h
Alembic Pharma gets USFDA nod for generic medication
The approved Abbreviated New Drug Application (ANDA) is therapeutically equivalent to GlaxoSmithKline LLC's Lamictal XR ...
The Financial Express20h
USDA gives nod to Alembic Pharma’s generic formulation to treat seizures
Alembic has a cumulative total of 216 ANDA approvals (188 final approvals and 28 tentative approvals) from USFDA.
National Institute for Health and Care Excellence21h
Consultation on NHS England proposals for a phased launch of obesity injection
Proposals for a phased launch of the obesity injection tirzepatide have been set out, as a consultation begins. NHS England ...
Alembic Pharma stock gains over 6% after USFDA approval for drug
The stock hits an intraday high on Thursday, October 3, 2024, after getting approval from USFDA for general medication drug.